Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector




















Sort by: Date|Relevance

BioNTech, CureVac, EXMceuticals - reaching their goal with government support

In the fight against the spread of the Corona Pandemic, a great deal of commitment is required from companies. This situation also offers the opportunity to rethink and change existing work processes and procedures. Product ranges are being expanded and new possibilities and a...

Biopharma Has Three 2020 Shots on Goal in Pediatric Liver Diseases

The events in that trio are presented in a ROTH Capital Partners report. In a Feb. 3 research note, ROTH Capital Partners analyst Yasmeen Rahimi reported that Albireo Pharma Inc. (ALBO:NASDAQ) plans to launch three clinical trials this year in the same num...

Disruptive. Transformative. Empowering. Integrated Digital Care for the Future.

CareSpan Health Inc. ( TSX-V.CSPN , Forum ) is a disruptive, transformative, and empowering company providing a digital healthcare platform that integrates digital care tools, capabilities, and data in one place. The company's proprietary "Clinic-in-the Cloud" is a c...

Ardelyx's Shares Soar 65% as Tenapanor Phase 3 Study Hits the Mark

Clinical-stage specialized biopharmaceutical company Ardelyx announced positive results today for its phase 3 AMPLIFY study for tenapanor aimed at improving treatment for cardiorenal diseases. This morning clinical-stage biopharmaceutical developer of medicines for th...

Commerzbank, Desert Gold, Deutsche Bank - Money supply increases significantly

There are various financial indicators in an economy that allow assessments of the current state. An important indication is, for example, the amount of money supply and its change. However, the amount of money is still divided into three classes according to its availability....

How a junior copper and gold explorer added the coveted Santa Cecilia project to its portfolio

The copper price has had a booming 2021 — having reached an all-time high of US$4.90 in May of this year — and companies in the space have been reaping the benefits of this year’s hottest metal. Meet Vancouver, BC-based Torq Resources Inc. ( TSXV:TORQ ,...

How This Gold Company Builds its Mining Activities While Caring About the Environment

The new gold rush is on, and investors are laser-focussed on companies that can ‘deliver the goods’…both as explorers and producers. Based out of Montreal, Monarch Mining Corp. ( TSX.GBAR , OTCQX: GBARF , Forum ) is a fully integrated mining company th...

Meet the Fully-Integrated Gold Mining Company That Owns 4 Advanced Projects

The new gold rush is on, and investors are laser-focussed on companies that can ‘deliver the goods’…both as explorers and producers. Based out of Montreal, Monarch Mining Corp. ( TSX.GBAR , OTCQX: GBARF , Forum ) is a fully integrated mining company th...

Dermira's Phase 2b Atopic Dermatitis Trial Results Send Shares 25% Higher

Dermira shares traded higher today after the firm released positive data from its phase 2b study of lebrikizumab in patients with atopic dermatitis at the Las Vegas Fall Clinical Dermatology Conference. Yesterday afternoon, Dermira Inc. (DERM:NASDAQ) , a biopharmaceu...

Axsome Therapeutics Shares Open 82% Higher on Phase 3 MDD Trial Outcome

Axsome Therapeutics shares reached a new 52-week high price today after the company reported that its AXS-05 drug achieved primary endpoint in the GEMINI Phase 3 trial in Major Depressive Disorder. The firm indicated that the positive results support a New Drug Application fil...
1 2 3 4 5 6 7 8 9 10 ...